Etigilimab with Nivolumab in Locally Advanced or Metastatic Solid Tumors - Clinical Trial
What is the Purpose of this Study?
We are doing this study to see if the study drugs, etigilimab and nivolumab, are safe and effective for fighting your cancer.
Who Can Participate in the Study?
Adults with cancer that:
- Consists of solid tumors
- Is recurrent, locally advanced, or metastatic
What is Involved?
If you choose to join this study, you will:
- Get the study drugs, etigilimab and nivolumab, by I.V. once every 2 weeks
- Give blood and urine samples
- Have regular CT or MRI scans